Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced Esophagogastric, Hepatopancreaticobiliary, Colorectal or Lung Cancer

NCT05705492 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

66

Enrollment

OTHER

Sponsor class

Conditions

Advanced Malignant Solid Neoplasm
Advanced Biliary Tract Carcinoma
Advanced Esophageal Carcinoma
Metastatic Esophageal Carcinoma
Locally Advanced Colorectal Carcinoma
Locally Advanced Esophageal Carcinoma
Locally Advanced Gastric Carcinoma
Metastatic Colorectal Carcinoma (mCRC)
Advanced Lung Carcinoma
Locally Advanced Hepatocellular Carcinoma

Interventions

DRUG: Olanzapine
DRUG: Placebo Administration
OTHER: Questionnaire Administration

Sponsor

OHSU Knight Cancer Institute

Collaborators

[object Object]
[object Object]